Bold claim: Early-onset gastric cancer is a growing blind spot in global health, even as overall gastric cancer deaths drop. But here’s the twist: this younger form shows distinct biology and risks that demand targeted prevention.
Global patterns show gastric cancer remains among the top five causes of cancer deaths worldwide. While overall incidence has fallen, cases diagnosed before age 50—early-onset gastric cancer (EOGC)—display unique features and often poorer outcomes. Key characteristics include diffuse histology, a predominance of signet ring cells, and a tendency toward worse prognosis. Known environmental and lifestyle risk factors, such as Helicobacter pylori infection, smoking, and high-salt diets, contribute to these patterns. Yet most global studies haven’t focused specifically on EOGC, making deeper investigation into its distribution, risk factors, and future trends essential for effective prevention.
A team from Chongqing Medical University in China conducted the first comprehensive global analysis of EOGC using Global Burden of Disease (GBD) 2021 data, covering 1990–2021 (DOI: 10.20892/j.issn.2095-3941.2025.0320). Published in Cancer Biology & Medicine, the study reports a 2.9% annual decline in global mortality but notes widening disparities between high- and low-income regions. The researchers identify smoking and high-salt diets as major risk factors, accounting for 7.1% and 7.7% of disability-adjusted life years (DALYs), respectively.
The study evaluated 371 diseases across 204 countries, applying Bayesian age–period–cohort modeling and joinpoint regression to gauge the global burden of EOGC. In 2021, roughly 125,000 new EOGC cases occurred worldwide, with about 78,000 deaths and 3.86 million DALYs. Incidence peaked for ages 45–49, and males showed higher prevalence, while mortality risk was higher for females under 30. Both age-standardized incidence and mortality rates fell globally from 1990 to 2021, notably in East Asia and Europe, though several Sub-Saharan African nations saw increases.
Geographically, smoking contributed more than 10% of DALYs in East Asia and Central Europe, while high-salt diets consistently impacted populations worldwide. Socioeconomic development strongly influenced disparities: high-income regions reduced burdens through regular screening and health education, whereas low-income regions faced growing burdens due to limited healthcare access and population growth. Projections indicate the global downward trend will continue through 2040.
EOGC poses a particularly tricky public health challenge because it affects people in their most productive years. The study suggests that preventive measures—smoking cessation, reducing salt intake, and eradicating H. pylori infection—can substantially lower the disease burden, but these strategies must be tailored to local contexts. In low-resource settings, strengthening healthcare infrastructure and expanding access to screening are critical steps to reduce disparities.
Wei Wang, corresponding author, Chongqing Medical University
The findings underscore the need to blend lifestyle modification, early detection, and sound public health policy to address EOGC worldwide. In high-risk regions like East Asia, dietary interventions and early endoscopic screening should be prioritized, while in low-income areas, investment in healthcare systems and public awareness programs is essential. Interventions such as tobacco taxation, clearer food labeling, and salt-reduction campaigns could further curb these risks. Looking ahead, integrating epidemiological data with genomic and environmental monitoring will help pinpoint vulnerable populations and refine precision prevention strategies against EOGC.
Source:
Zhang, X., et al. (2025). Early-onset gastric cancer global burden profile, trends, and contributors. Cancer Biology and Medicine. DOI: 10.20892/j.issn.2095-3941.2025.0320. https://www.cancerbiomed.org/content/early/2025/08/20/j.issn.2095-3941.2025.0320
Note: This rewritten content preserves the original meaning and key information while presenting it with clearer explanations, expanded context, and a flow suitable for beginners. It is not medical advice. For medical decisions, consult a professional.
